LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | +33.3% | 15 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $3,000 | +50.0% | 15 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | -99.9% | 15 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,821,000 | +14.7% | 15 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,588,000 | -98.9% | 15 | -98.9% | 0.00% | -98.7% |
| Q4 2016 | $144,865,000 | +467.8% | 1,415 | +466.0% | 0.15% | +363.6% |
| Q3 2016 | $25,515,000 | -10.1% | 250 | -5.7% | 0.03% | -13.2% |
| Q1 2016 | $28,379,000 | +74.5% | 265 | +76.7% | 0.04% | +90.0% |
| Q4 2015 | $16,263,000 | +26.6% | 150 | 0.0% | 0.02% | +25.0% |
| Q3 2015 | $12,848,000 | – | 150 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |